Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Feb 26, 2026
Sale
Shares
8,452
Price
$1.35
Total Value
$11.41K
Shares Held After
1,524,713
% of Holdings
0.6%

Neuronetics, Inc. (STIM)

MACAN WILLIAM ANDREW — EVP, CLO and CS
Feb 26, 2026
Sale
Shares
3,427
Price
$1.35
Total Value
$4.63K
Shares Held After
880,134
% of Holdings
0.4%
Feb 26, 2026
Sale
Shares
16,313
Price
$7.01
Total Value
$114.29K
Shares Held After
154,657
% of Holdings
9.5%
Feb 26, 2026
Sale
Shares
17,924
Price
$34.44
Total Value
$617.30K
Shares Held After
174,144
% of Holdings
9.3%
Feb 26, 2026
Sale
Shares
165,408
Price
$33.63
Total Value
$5.56M
Shares Held After
477,783
% of Holdings
25.7%

BIOMARIN PHARMACEUTICAL INC (BMRN)

Davis George Eric — EVP, Chief Legal Officer
Feb 26, 2026
Sale
Shares
26,061
Price
$61.36
Total Value
$1.60M
Shares Held After
72,453
% of Holdings
26.5%

BIOMARIN PHARMACEUTICAL INC (BMRN)

Friberg Gregory R — EVP, Chief R&D Officer
Feb 26, 2026
Sale
Shares
6,326
Price
$60.38
Total Value
$381.94K
Shares Held After
37,578
% of Holdings
14.4%
Feb 26, 2026
Sale
Shares
711
Price
$54.28
Total Value
$38.59K
Shares Held After
1,480
% of Holdings
32.5%
Feb 26, 2026
Sale
Shares
6,329
Price
$53.67
Total Value
$339.67K
Shares Held After
2,191
% of Holdings
74.3%
Feb 26, 2026
Sale
Shares
2,638
Price
$276.32
Total Value
$728.92K
Shares Held After
85,096
% of Holdings
3.0%
Feb 26, 2026
Sale
Shares
5,103
Price
$275.28
Total Value
$1.40M
Shares Held After
87,734
% of Holdings
5.5%
Feb 25, 2026
Purchase
Shares
758
Price
$2.96
Total Value
$2.24K
Shares Held After
758
% of Holdings
100.0%

uniQure N.V. (QURE)

Kapusta Matthew C — Director
Feb 25, 2026
Sale
Shares
12,378
Price
$23.86
Total Value
$295.34K
Shares Held After
639,076
% of Holdings
1.9%
Feb 25, 2026
Sale
Shares
7,579
Price
$19.41
Total Value
$147.11K
Shares Held After
26,780
% of Holdings
22.1%

Caribou Biosciences, Inc. (CRBU)

Kelly Timothy P — Chief Technology Officer
Feb 25, 2026
Sale
Shares
6,228
Price
$1.93
Total Value
$12.02K
Shares Held After
73,125
% of Holdings
7.8%
Feb 25, 2026
Purchase
Shares
6,100
Price
$4.74
Total Value
$28.89K
Shares Held After
183,544
% of Holdings
3.3%
Feb 25, 2026
Sale
Shares
523
Price
$18.04
Total Value
$9.43K
Shares Held After
209,641
% of Holdings
0.2%
Feb 25, 2026
Sale
Shares
3,108
Price
$18.04
Total Value
$56.07K
Shares Held After
210,164
% of Holdings
1.5%

AbbVie Inc. (ABBV)

Siatis Perry C — EVP, GC AND SECRETARY
Feb 25, 2026
Sale
Shares
22,381
Price
$230.00
Total Value
$5.15M
Shares Held After
38,137
% of Holdings
37.0%

uniQure N.V. (QURE)

KLEMT CHRISTIAN — Chief Financial Officer
Feb 25, 2026
Sale
Shares
6,217
Price
$23.86
Total Value
$148.34K
Shares Held After
211,513
% of Holdings
2.9%

Immunovant, Inc. (IMVT)

Gloria Melanie — Chief Operating Officer
Feb 25, 2026
Sale
Shares
942
Price
$28.90
Total Value
$27.22K
Shares Held After
170,273
% of Holdings
0.6%

Immunovant, Inc. (IMVT)

Gloria Melanie — Chief Operating Officer
Feb 25, 2026
Sale
Shares
859
Price
$28.16
Total Value
$24.19K
Shares Held After
171,215
% of Holdings
0.5%

Immunovant, Inc. (IMVT)

Gloria Melanie — Chief Operating Officer
Feb 25, 2026
Sale
Shares
1,437
Price
$26.98
Total Value
$38.77K
Shares Held After
172,074
% of Holdings
0.8%

Gemini Therapeutics, Inc. (GMTX)

Franchi Jean M. — Chief Financial Officer
Feb 25, 2026
Sale
Shares
353
Price
$69.06
Total Value
$24.38K
Shares Held After
70,990
% of Holdings
0.5%

Q32 Bio Inc. (QTTB)

Kalowski Lee — CFO and President
Feb 25, 2026
Sale
Shares
3,995
Price
$4.51
Total Value
$18.04K
Shares Held After
35,943
% of Holdings
10.0%
Feb 25, 2026
Sale
Shares
9,896
Price
$4.51
Total Value
$44.67K
Shares Held After
89,104
% of Holdings
10.0%

Q32 Bio Inc. (QTTB)

Violette Shelia M. — Chief Scientific Officer
Feb 25, 2026
Sale
Shares
2,815
Price
$4.51
Total Value
$12.71K
Shares Held After
55,569
% of Holdings
4.8%

GLOBUS MEDICAL INC (GMED)

Huller Kelly — EVP, GC, Corporate Secretary
Feb 25, 2026
Sale
Shares
20,000
Price
$94.50
Total Value
$1.89M
Shares Held After
0
% of Holdings
100.0%
Feb 25, 2026
Sale
Shares
33,687
Price
$7.00
Total Value
$235.96K
Shares Held After
170,970
% of Holdings
16.5%
Feb 25, 2026
Purchase
Shares
2,000
Price
$1.49
Total Value
$2.98K
Shares Held After
1,906,186
% of Holdings
0.1%
Feb 25, 2026
Sale
Shares
1,300
Price
$36.68
Total Value
$47.68K
Shares Held After
459,859
% of Holdings
0.3%
Feb 25, 2026
Sale
Shares
10,436
Price
$35.96
Total Value
$375.28K
Shares Held After
461,159
% of Holdings
2.2%
Feb 25, 2026
Sale
Shares
46,517
Price
$35.11
Total Value
$1.63M
Shares Held After
471,595
% of Holdings
9.0%

Edwards Lifesciences Corp (EW)

BOBO DONALD E JR — CVP,Strategy/Corp Development
Feb 25, 2026
Sale
Shares
24,000
Price
$83.84
Total Value
$2.01M
Shares Held After
21,266
% of Holdings
53.0%
Feb 25, 2026
Sale
Shares
7,040
Price
$51.71
Total Value
$364.04K
Shares Held After
8,520
% of Holdings
45.2%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Sachdev Amit — EVP Chief Patient & Ext Af Off
Feb 25, 2026
Sale
Shares
1,846
Price
$486.35
Total Value
$897.80K
Shares Held After
55,570
% of Holdings
3.2%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Feb 25, 2026
Sale
Shares
260
Price
$486.35
Total Value
$126.45K
Shares Held After
46,763
% of Holdings
0.6%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

McKechnie Duncan — EVP, Chief Commercial Officer
Feb 25, 2026
Sale
Shares
2,410
Price
$489.00
Total Value
$1.18M
Shares Held After
17,559
% of Holdings
12.1%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

McKechnie Duncan — EVP, Chief Commercial Officer
Feb 25, 2026
Sale
Shares
2,500
Price
$486.35
Total Value
$1.22M
Shares Held After
19,969
% of Holdings
11.1%
Feb 25, 2026
Sale
Shares
700
Price
$275.00
Total Value
$192.50K
Shares Held After
92,837
% of Holdings
0.7%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Ambrose Kristen — SVP & Chief Accounting Officer
Feb 25, 2026
Sale
Shares
223
Price
$486.35
Total Value
$108.46K
Shares Held After
6,981
% of Holdings
3.1%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Biller Jonathan — EVP and Chief Legal Officer
Feb 25, 2026
Sale
Shares
945
Price
$486.35
Total Value
$459.60K
Shares Held After
13,659
% of Holdings
6.5%

iRhythm Holdings, Inc. (IRTC)

Wilson Daniel G. — Chief Financial Officer
Feb 25, 2026
Sale
Shares
5,188
Price
$135.42
Total Value
$702.55K
Shares Held After
30,694
% of Holdings
14.5%

iRhythm Holdings, Inc. (IRTC)

Turakhia Minang — CHIEF MED/SCI OFCR EVP ADVTECH
Feb 25, 2026
Sale
Shares
7,804
Price
$135.42
Total Value
$1.06M
Shares Held After
48,899
% of Holdings
13.8%

VERTEX PHARMACEUTICALS INC / MA (VRTX)

Atkinson Edward Morrow III — EVP, Chief Technical Ops. Off.
Feb 25, 2026
Sale
Shares
668
Price
$486.35
Total Value
$324.88K
Shares Held After
18,432
% of Holdings
3.5%

Addus HomeCare Corp (ADUS)

BLESSING CLIFF DONALD — EVP, Chief Development Officer
Feb 25, 2026
Sale
Shares
177
Price
$105.36
Total Value
$18.65K
Shares Held After
12,361
% of Holdings
1.4%

Addus HomeCare Corp (ADUS)

Anderson Darby — EVP, Chief Govt Rel Officer
Feb 25, 2026
Sale
Shares
396
Price
$105.36
Total Value
$41.72K
Shares Held After
46,246
% of Holdings
0.8%

Addus HomeCare Corp (ADUS)

Stevenson Roberton James — EVP, Chief HR Officer
Feb 25, 2026
Sale
Shares
284
Price
$105.36
Total Value
$29.92K
Shares Held After
14,030
% of Holdings
2.0%

Addus HomeCare Corp (ADUS)

WATTENBARGER MICHAEL D. — EVP, Chief Information Officer
Feb 25, 2026
Sale
Shares
300
Price
$105.36
Total Value
$31.61K
Shares Held After
9,444
% of Holdings
3.1%

Addus HomeCare Corp (ADUS)

RAINES MONICA — EVP, CCO and Quality Officer
Feb 25, 2026
Sale
Shares
219
Price
$105.36
Total Value
$23.07K
Shares Held After
13,801
% of Holdings
1.6%
Version: v26.3.33